Clinicalguidelinefortreatmentofpulmonaryarterialhypertension(PAH)hasbeenchangingduringthepast10yearswithdevelopmentoftargetedtherapyforPAH.TreatmentofPAHshouldincludegeneralmeasuresandsupportivecare,treatmentofassociateddisease,targetedtreatmentforPAH,andlungtransplantationinadvancedcases.TargetedtherapyforPAHcanimprovesymptom,qualityoflifeandtimetoclinicalworseninginPAHpatients.Regularfollow-uptoevaluatethetreatmentefficacyisessentialandinsufficienttreatmentefficacyshouldbemodifiedwithotherclassofmedicationorpreparinglungtransplantations.ResearchfornewmedicationisactivelyperformedandnoveldrugisexpectedtobeimprovingsurvivalofPAHpatients.
点击下方,查看原文吧
北京正规治疗白癜风需要多少钱北京白癜风治疗最新方法